- Six-in-One Parasite Protection in One Chewable
Tablet
- Six of Six Potential Blockbusters from Elanco Now
In-Market
GREENFIELD, Ind., Jan. 23,
2025 /PRNewswire/ -- Elanco Animal Health
Incorporated (NYSE: ELAN) today announced Credelio Quattro™
(lotilaner, moxidectin, praziquantel, and pyrantel chewable
tablets) is now available for veterinarians to order at
CredelioQuattroVet.com. With four established and powerful
ingredients, Credelio Quattro is designed to deliver the broadest
i parasite protection of its kind. Credelio
Quattro is the first and only monthly chewable tablet of its
kind to protect against six different types of parasites,
including three risky intestinal worms that can be passed to
humans:
- Tapeworms
- Roundworms
- Hookwormsii
- Heartworms
- Ticks
- Fleas
"Today is a historic day as we bring veterinarians and pet
owners peace of mind with the broadest i parasite
protection of its kind for dogs," said Bobby Modi, Executive Vice President, U.S. Pet
Health and Global Digital Transformation. "Our research shows 94%
of dog owners believe that proactive treatment for intestinal
worms, including tapeworms, is a top priority. And when looking for
intestinal worm protection for their dog, owners care most about
product effectiveness, parasite coverage and duration of
protection. By providing the broadesti range of parasite
protection of its kind, covering six parasites in a single,
chewable, Credelio Quattro delivers on pet owner expectations,
while strengthening Elanco's market presence and positioning us for
continued growth in the parasiticide segment."
But the survey shows an important gap where pet owners need to
lean in to better protect their beloved pets against risky
parasites. Just one in three respondents believe that fleas and
ticks are a risk year-round; and only half of dog owners surveyed
protect against heartworm disease year-round.iii With
the geographic spread of parasites and increasing disease pressure,
the importance of year-round protection is more significant than
ever.
Broad. Fast. Tasty. Tough.
The broad range of parasite
protection from Credelio Quattro in a single, chewable monthly
tablet makes it easy for pet parents to protect against some of the
most common and challenging parasites. According to studies,
Credelio Quattro has been shown to be 100% efficacious against
tapeworms with its industry-established dose of praziquantel (one
of the active ingredients found in Credelio
Quattro).iv Credelio Quattro also contains
lotilaner that kills ticksv twice as
fastvi as sarolaner in Simparica Trio®
and afoxolaner in NexGard®.vii
"Parasites like tapeworms, fleas and ticks can carry dangerous
diseases and some of these can spread from dogs to humans," said
Dr. Casey Locklear, veterinarian and
parasiticide lead for Elanco Animal Health. "The Companion Animal
Parasite Council (CAPC) recommends year round prevention of
parasites, even during the winter months and specifically mentions
the need for monthly deworming of dogs with praziquantel in areas
where a certain type of tapeworm – E. granulosus tapeworms –
are endemic."viii
Veterinarians can place their orders today at
CredelioQuattroVet.com. Credelio Quattro will make its debut at the
Veterinary Meeting & Expo (VMX) in Orlando from January
25-29, 2025. Attendees can visit Booth #4617 to place their
orders, learn more and speak with experts on-site.
Launching Credelio Quattro is another milestone in Elanco's
historic era of innovation and delivery as it is one of six
potential blockbuster products from Elanco available in the
U.S.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE:
ELAN) is a global leader in animal health dedicated to innovating
and delivering products and services to prevent and treat disease
in farm animals and pets, creating value for farmers, pet owners,
veterinarians, stakeholders and society as a whole. With 70 years
of animal health heritage, we are committed to breaking boundaries
and going beyond to help our customers improve the health of
animals in their care, while also making a meaningful impact on our
local and global communities. At Elanco, we are driven by our
vision of Food and Companionship Enriching Life and our Elanco
Healthy Purpose™ sustainability pillars – all to advance the health
of animals, people, the planet and our enterprise. Learn more
at www.elanco.com.
Indications: Credelio Quattro is indicated for the
prevention of heartworm disease and the treatment and control of
roundworm, hookworm* and tapeworm infections. Credelio Quattro
kills adult fleas and is indicated for the treatment and prevention
of flea infestations and the treatment and control of tick
infestations for 1 month in dogs and puppies 8 weeks of age and
older and weighing 3.3 pounds or greater.
Important Safety Information: Lotilaner, an
ingredient in Credelio Quattro, belongs to the isoxazoline class
and has been associated with neurologic adverse reactions like
tremors, ataxia, and seizures even in dogs without a history of
seizures. Use with caution in dogs with a history of seizures or
neurologic disorders. Dogs should be tested for existing heartworm
infections before Credelio Quattro administration as it is not
effective against adult D. immitis. The safe use in
breeding, pregnant, or lactating dogs has not been evaluated. The
most frequently reported adverse reactions in clinical trials were
vomiting and diarrhea. For complete safety information, please see
Credelio Quattro product label or ask your veterinarian.
*Uncinaria stenocephala
NexGard is a registered trademark of Boehringer Ingelheim Animal
Health USA Inc. Simparica TRIO is a registered trademark
of Zoetis Services LLC.
Credelio Quattro, Elanco and the diagonal bar logo are
trademarks of Elanco or its affiliates. Other company and product
names are trademarks of their respective owners. © 2025 Elanco or
its affiliates.
|
____________________
|
|
i Based on
label comparison of the number of parasite types covered in a
chewable that covers targets ticks.
|
|
ii
Uncinaria stenocephala
|
|
iii Elanco
Animal Health, Data on File. February 2024.
|
|
iv Echinococcus granulosus,
Dipylidium caninum, and Taenia pisiformis
|
|
v Amblyomma americanum (lone
star tick)
|
|
vi Based on the time to statistical
significance vs control in a single study on Day 21 and Day 28 for
reinfestations. The study compared Credelio™ (lotilaner)—not
Credelio Quattro™, which contains lotilaner as well as moxidectin,
praziquantel, and pyrantel—to the active ingredients in Simparica
Trio™ (sarolaner, moxidectin, and pyrantel) and NexGard™
(afoxolaner).
|
|
vii Reif KE,
Kollasch TM, Neilson JC, Herrin BH, Ryan WG, Bell MC, Beltz
MS, Dryden MW, Jesudoss Chelladurai JRJ, Miller KR, Sutherland CJ.
Comparative speed of kill provided by lotilaner (Credelio™),
sarolaner (Simparica Trio™), and afoxolaner (NexGard™) to control
Amblyomma americanum infestations on dogs. Parasite Vectors. 2024
Jul 20;17(1):313.
|
|
viii
Echinococcus spp. Companion Animal Parasite Council
Guidelines. Updated Sept 13, 2022. Accessed Oct 10, 2024.
https://capcvet.org/guidelines/echinococcus-spp/.
|
Investor Contact: Tiffany Kanaga (765) 740-0314
tiffany.kanaga@elancoah.com
Media Contact: Season Solorio (765)
316-0233 season.solorio@elancoah.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/now-available-credelio-quattro-lotilaner-moxidectin-praziquantel-and-pyrantel-chewable-tablets-provides-broadesti-parasite-protection-of-its-kind-302357947.html
SOURCE Elanco Animal Health
